https://cambridgebrc.nihr.ac.uk/wp-content/uploads/2024/09/Cambridge_Biomedical_Research_Centre_Cytosponge1-1024x683-1.jpg
683
1024
Amanda
https://cambridgebrc.nihr.ac.uk/wp-content/uploads/2024/04/Cambridge_BRC_NIHR_logo.png
Amanda2024-11-28 11:06:032025-01-10 18:10:43Landmark ‘Pill-On-A-Thread’ cancer screening trial welcomes first participantsThe NIHR Cambridge BRC is part of the NIHR and hosted by Cambridge University Hospitals NHS Foundation Trust in partnership with the University of Cambridge. We are at the heart of the Cambridge Biomedical Campus, Europe’s largest health research area.
Contact Us
Cambridge Biomedical Research Centre
Box 277
Hills Road
Cambridge
CB2 0QQ
Tel: 01223 348490
🗓️ Join this free regional research event to learn about the @NIHRresearch Insight programme on Wednesday 13 May, 10am to 5pm.
🔎 Find out how to apply to start #YourPathInResearch and meet researchers in the #EastofEngland.
Register your free place here ➡️https://www.eventbrite.co.uk/e/insight-research-conference-2026-tickets-1981735621591?aff=oddtdtcreator
We've launched lots of exciting funding and development opportunities in the last week!
Find them below 👇 or visit our website to see the full list of opportunities available: https://www.nihr.ac.uk/funding-opportunities
⏳ Final call: Applications are closing soon for Non-Executive Members of our new Council!
Help shape the strategic direction of health and care research in the UK. Apply by 10 April, 1pm ➡️https://www.nihr.ac.uk/honorary-and-specialty/nihr-council-non-executive-council-members


















A Feasibility Study of the Therapeutic Response and Durability of Short-term Androgen-targeted Therapy in Early Prostate Cancer Managed with Surveillance: The Therapeutics in Active Prostate Surveillance (TAPS01) Study
Multi-omic machine learning predictor of breast cancer therapy response
A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study
Hyperpolarized carbon-13 MRI for early response assessment of neoadjuvant chemotherapy in breast cancer patients
Clinical Impact of the Predict Prostate Risk Communication Tool in Men Newly Diagnosed with Nonmetastatic Prostate Cancer: A Multicentre Randomised Controlled Trial